Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $678000.0.

  • Utah Medical Products' Tax Provisions rose 1006.49% to $678000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 162.88%. This contributed to the annual value of $3.3 million for FY2024, which is 1980.37% down from last year.
  • Per Utah Medical Products' latest filing, its Tax Provisions stood at $678000.0 for Q3 2025, which was up 1006.49% from $788000.0 recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Tax Provisions ranged from a high of $1.5 million in Q4 2022 and a low of $616000.0 during Q3 2024
  • Over the past 5 years, Utah Medical Products' median Tax Provisions value was $874000.0 (recorded in 2021), while the average stood at $924789.5.
  • As far as peak fluctuations go, Utah Medical Products' Tax Provisions surged by 11069.28% in 2021, and later tumbled by 5067.48% in 2023.
  • Utah Medical Products' Tax Provisions (Quarter) stood at $1.0 million in 2021, then skyrocketed by 41.28% to $1.5 million in 2022, then crashed by 50.67% to $731000.0 in 2023, then dropped by 2.6% to $712000.0 in 2024, then dropped by 4.78% to $678000.0 in 2025.
  • Its Tax Provisions stands at $678000.0 for Q3 2025, versus $788000.0 for Q2 2025 and $817000.0 for Q1 2025.